XOMA 052 Orphan Drug Designation for Behcet's Disease Recommended by European ... - MarketWatch (press release)
Posted by admin! / Under Drug Allergy
XOMA 052 Orphan Drug Designation for Behcet's Disease Recommended by European ... MarketWatch (press release) The EMA's orphan drug program is designed to promote the development of drugs to treat life-threatening or chronically debilitating conditions with a ... |
Published on Friday 30th of July 2010 03:47:10 AM



